Table 1: Subject characteristics.

Four-channelPlaceboDual-channel
( )( )( )

Age (years)63.4 ± 10.667.0 ± 9.064.6 ± 8.3
Gender (male/female)8/88/98/6
Brunnstrom (I/II/IV)1/4/111/6/81/4/9
Time since onset (days)41.3 ± 29.441.5 ± 20.441.6 ± 22.1

Four-channel, placebo, and dual-channel denote groups which received four-channel FES, four-channel FES placebo, and dual-channel FES, respectively. Value: mean ± SD.